P-glycoprotein and Drug Resistance in Lung Cancer
Author Information
Author(s): Y Abe, M Nakamura, Y Ohnishi, M Yoshimura, E Otal, Y Ozeki, Y Oshika, T Tokunaga, H Yamazaki, Y Ueyama, T Ogata, N Tamaoki
Primary Institution: Tokai University School of Medicine
Hypothesis
Acquired multidrug resistance is induced by the increased expression of P-glycoprotein in lung cancer in vivo.
Conclusion
The study suggests that overexpression of P-glycoprotein is related to acquired multidrug resistance in lung cancer.
Supporting Evidence
- VCR-resistant variants showed increased levels of MDR1 expression.
- LC-6 and Lu-24 were initially sensitive to both vincristine and doxorubicin.
- Co-administration of CysA reversed acquired drug resistance in LC-6R.
Takeaway
This study found that lung cancer cells can become resistant to drugs because they produce more of a protein called P-glycoprotein, which helps them survive treatment.
Methodology
The study involved creating drug-resistant variants of lung cancer xenografts and testing their sensitivity to chemotherapy drugs while measuring P-glycoprotein expression.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website